Actively Recruiting
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Led by Thomas Jefferson University · Updated on 2026-03-17
200
Participants Needed
1
Research Sites
314 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a pilot trial to assess how measures of inflammation are correlated with Social Determinants of Health (SDoH) in breast cancer patients. Expected duration of subject participation is one single time point. The patients will fill out questionnaires and provide a plasma sample.
CONDITIONS
Official Title
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female
- 18 years old or older at time of consent
- Biopsy proven invasive breast cancer or ductal carcinoma in situ
- Has not yet received any cancer therapy for breast cancer diagnosis
- ECOG Performance Status less than 2
- Able to provide consent
- English speaking
You will not qualify if you...
- Started therapy or had definitive oncologic surgery for breast cancer
- Another malignancy within the past 6 months except for non-melanomatous skin lesion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Actively Recruiting
Research Team
N
Nicole Simone, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here